|
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
NEW HAVEN, Conn.--(BUSINESS WIRE)--Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
Companies mentioned in this article: Ikonisys, Inc.NEW HAVEN, Conn. -- (BUSINESS WIRE) -- Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Preventi
NEW HAVEN, Conn.--(BUSINESS WIRE)--Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); NEW HAVEN, Conn.- (Business Wire) Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.oncoFISH cervical is a...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
NEW HAVEN, Conn.Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.oncoFISH ...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
NEW HAVEN, Conn.--(BUSINESS WIRE)-- Ikonisys announced today that they will exhibit their proprietary oncoFISH(R) cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February...
|
|
|
UH Case Medical Center researchers publish promising findings for advanced cervical cancer
Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer.Published in the February...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at t
NEW HAVEN, Conn.--(BUSINESS WIRE)-- Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at
Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.oncoFISH cervical : is a...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Ce
Ikonisys announced today that they will exhibit their proprietary oncoFISH(R) cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.oncoFISH cervical is a...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at t
NEW HAVEN, Conn.--(BUSINESS WIRE)--Ikonisys announced today that they will exhibit their proprietary oncoFISH cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at t
Ikonisys announced today that they will exhibit their proprietary oncoFISH(R) cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.oncoFISH cervical is a...
|
|
|
Cervical cancer: Regiment with new drug triapine provides both significant reduction in cancer disease and cancer control
Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer.Published in the February...
|
|
|
Health Canada approves CERVARIX(TM), new GSK cervical cancer vaccine
Shown to provide the longest protection against cervical cancer MISSISSAUGA, ON, Feb.9 /CNW/ - Health Canada has approved CERVARIX(TM) (Human papillomavirus vaccine (Types 16 and 18) Recombinant, AS04 adjuvanted). CERVARIX(TM) is a vaccine...
|
|
|
Report: 40 percent of cancers are preventable
About 40 percent of cancers could be prevented if people stopped smoking and overeating, limited their alcohol, exercised regularly and got vaccines targeting cancer-causing infections, experts say.To mark World Cancer day on Thursday,...
|
|
|
Report: 40 percent of cancers are preventable
About 40 percent of cancers could be prevented if people stopped smoking and overeating, limited their alcohol, exercised regularly and got vaccines targeting cancer-causing infections, experts say.To mark World Cancer day on Thursday,...
|
|
|
Health Canada approves CERVARIX(TM), new GSK cervical cancer vaccine
/CNW/ - Health Canada has approved CERVARIX(TM) (Human papillomavirus vaccine (Types 16 and 18) Recombinant, AS04 adjuvanted).CERVARIX(TM) is a vaccine intended to protect females against cervical cancer (cancer of the lower part of the...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
(BusinessWire) Ikonisys announced today that they will exhibit their proprietary oncoFISH(R) cervical test at the Eurogin 2010 Cervical Cancer Prevention Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to...
|
|
|
Another World Cancer Day: Nigeria's Prognosis
Even as a student of medical laboratory science, I never for once gave it a thought that cancer could be far-reaching and deleterious until an encounter that I had in 2007 at the Pathology department of Nigerias premier teaching hospital, University...
|
|
|
Cervical cancer high in Arua district
By Richard Adrama CANCER of the cervix ranks highest among the various cancer types causing death in Arua, the district health officer, Dr.Patrick Anguzu, has said. Anguzu said up to 29 cervical cancer deaths were registered last...
|
|
|
Cancer Screening Under Review
Ideas about who should be screened and how often vary widely among physicians and agencies.Jill U. Adams Los Angeles Times 1 Related links Find a Local Doctor Healthy Heart Month! You'd think there could be no downside to widespread screening for ...
|
|
|
CerMed Corporation to Present at Sachs Associates Third Annual European Global Lifescience Forum on February 1
CerMed Corporation, www.cermedcorp.com, an international womens healthcare medical device company that is commercializing three breakthrough products for cervical cancer screening and a womens controlled barrier contraceptive that protects against...
|
|
|
Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference
_ Ikonisys to Introduce Its Proprietary Molecular-Based Cervical Cancer Test to the Broader European Market at the Eurogin 2010 Cervical Cancer Prevention Conference.
|
|
|
Get tested to cut risk of cancer, women told
Calls are being made for women to be screened for cervical cancer as part of an awareness week.Cervical Cancer Prevention Week aims to highlight how women and girls can help themselves by going for checks and the HPV vaccination...
|
